[Plasmatic thyroid hormones during treatment of hyperthyroidism by carbimazol (author's transl)].
Plasmatic concentrations of thyroxine (T4-D-) and triiodothyronine (T3 RI) were evaluated in 32 Graves' diseases on treatment by carbimazol. Among 131 measures, T4 and T3 were dissociated in 56%, with T3 more elevated than T4 in 89%. Compensated hypothyroidism was frequently seen (35%).
D002231:Carbimazole / Q000627:therapeutic use*; D006111:Graves Disease / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D007037:Hypothyroidism / Q000097:blood; D013961:Thyroid Gland / Q000502:physiology; D013974:Thyroxine / Q000097:blood*; D014284:Triiodothyronine / Q000097:blood*
D014284:Triiodothyronine; D002231:Carbimazole; D013974:Thyroxine
Les hormones thyroïdiennes plasmatiques au cours du traitement des hyperthyroïdies par le carbimazole.